Li et al. [68] demonstrated that significant levels of TGF-β expression in patients were associated with poor survival; thus, TGF-β expression can predict a significantly worse prognosis for patients with LC [68]. The gene discussed is TGFB1; the disease is laryngotracheoesophageal cleft.